Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shi-Bi-Lin for Perennial Allergic Rhinitis
NCT00456755Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2004
- Primary completion
- Apr 2006
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in perennial allergic rhinitis (PAR) comparing Shi-Bi-Lin Arm with Placebo Arm (2 arms). Primary endpoint: Allergic Rhinitis Symptom Score Including Rhinorrhea, Nasal Obstruction, Sneezing, Itchy Nose and Itchy Eyes at 4 weeks. Started Mar 2004; status: completed.
02
Drugs
Shi-Bi-Lin
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00456755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456755.